Trial of AB Science’s Progressive MS Therapy to Continue Without Additional Patient Requirement
News
A Phase 3 clinical trial evaluating AB Science’s masitinib as a treatment for progressive multiple sclerosis can continue without having to add patients, an independent review board ... Read more